News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
510,607 Results
Type
Article (30127)
Company Profile (369)
Press Release (480099)
Multimedia
Podcasts (127)
Webinars (18)
Section
Business (136156)
Career Advice (436)
Deals (24762)
Drug Delivery (101)
Drug Development (66906)
Employer Resources (67)
FDA (12436)
Job Trends (10013)
News (239198)
Policy (19316)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (2)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (2)
2027 Genetown Elite (3)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (1855)
Academic (1)
Accelerated approval (37)
Adcomms (20)
Allergies (149)
Alliances (37134)
ALS (195)
Alzheimer's disease (1624)
Antibody-drug conjugate (ADC) (452)
Approvals (12901)
Artificial intelligence (590)
Autoimmune disease (285)
Automation (47)
Bankruptcy (177)
Best Places to Work (8468)
BIOSECURE Act (15)
Biosimilars (198)
Biotechnology (260)
Bladder cancer (175)
Brain cancer (67)
Breast cancer (673)
Cancer (5323)
Cardiovascular disease (455)
Career advice (401)
Career pathing (20)
CAR-T (326)
CDC (13)
Celiac Disease (1)
Cell therapy (885)
Cervical cancer (39)
Clinical research (58917)
Collaboration (2032)
Company closure (3)
Compensation (1036)
Complete response letters (70)
COVID-19 (2119)
CRISPR (107)
C-suite (1046)
Cystic fibrosis (141)
Data (7267)
Decentralized trials (1)
Denatured (45)
Depression (145)
Dermatology (76)
Diabetes (535)
Diagnostics (5309)
Digital health (46)
Diversity (8)
Diversity, equity & inclusion (19)
Drug discovery (310)
Drug pricing (99)
Drug shortages (19)
Duchenne muscular dystrophy (284)
Earnings (55145)
Editorial (43)
Employer branding (12)
Employer resources (61)
Events (88116)
Executive appointments (1002)
FDA (15741)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (34)
Funding (1568)
Gene editing (235)
Generative AI (51)
Gene therapy (712)
GLP-1 (923)
Government (2604)
Grass and pollen (8)
Guidances (333)
Healthcare (12918)
HIV (70)
Huntington's disease (52)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (101)
Immunology and inflammation (269)
Immuno-oncology (84)
Indications (180)
Infectious disease (2396)
Inflammatory bowel disease (214)
Inflation Reduction Act (11)
Influenza (109)
Intellectual property (261)
Interviews (53)
IPO (12176)
IRA (24)
Job creations (1939)
Job search strategy (348)
JPM (55)
Kidney cancer (18)
Labor market (49)
Layoffs (389)
Leadership (21)
Legal (3258)
Liver cancer (85)
Longevity (29)
Lung cancer (692)
Lymphoma (405)
Machine learning (55)
Management (17)
Manufacturing (889)
MASH (185)
Medical device (9384)
Medtech (9453)
Mergers & acquisitions (13691)
Metabolic disorders (1340)
mRNA (192)
Multiple sclerosis (173)
NASH (18)
Neurodegenerative disease (388)
Neuropsychiatric disorders (93)
Neuroscience (3002)
Neurotech (1)
NextGen: Class of 2026 (3696)
Non-profit (2709)
Now hiring (52)
Obesity (601)
Opinion (202)
Ovarian cancer (203)
Pain (199)
Pancreatic cancer (276)
Parkinson's disease (341)
Partnered (28)
Patents (506)
Patient recruitment (616)
Peanut (57)
People (44493)
Pharmaceutical (66)
Pharmacy benefit managers (9)
Phase 1 (18793)
Phase 2 (25934)
Phase 3 (19502)
Pipeline (7958)
Policy (173)
Postmarket research (1833)
Preclinical (7832)
Press Release (60)
Prostate cancer (282)
Psychedelics (60)
Radiopharmaceuticals (313)
Rare diseases (1036)
Real estate (3722)
Recruiting (28)
Regulatory (18031)
Reports (30)
Research institute (1919)
Resumes & cover letters (49)
Rett syndrome (38)
RNA editing (27)
RSV (61)
Schizophrenia (167)
Series A (280)
Series B (194)
Service/supplier (5)
Sickle cell disease (116)
Special edition (23)
Spinal muscular atrophy (154)
Sponsored (43)
Startups (2734)
State (1)
Stomach cancer (12)
Supply chain (102)
Tariffs (39)
The Weekly (80)
Vaccines (842)
Venture capital (97)
Weight loss (371)
Women's health (102)
Worklife (5)
Date
Today (129)
Last 7 days (759)
Last 30 days (3014)
Last 365 days (26497)
2026 (10849)
2025 (26546)
2024 (30140)
2023 (33604)
2022 (43709)
2021 (46637)
2020 (42591)
2019 (32185)
2018 (24091)
2017 (24506)
2016 (22907)
2015 (26832)
2014 (20021)
2013 (15812)
2012 (16606)
2011 (16263)
2010 (14959)
Location
Africa (460)
Alabama (80)
Alaska (4)
Arizona (181)
Arkansas (13)
Asia (32675)
Australia (5667)
California (11332)
Canada (3108)
China (1358)
Colorado (468)
Connecticut (456)
Delaware (383)
Europe (74002)
Florida (1563)
Georgia (383)
Hawaii (4)
Idaho (36)
Illinois (819)
India (89)
Indiana (527)
Iowa (16)
Japan (534)
Kansas (111)
Kentucky (27)
Louisiana (25)
Maine (42)
Maryland (1297)
Massachusetts (8693)
Michigan (332)
Minnesota (522)
Mississippi (4)
Missouri (119)
Montana (32)
Nebraska (15)
Nevada (108)
New Hampshire (67)
New Jersey (3136)
New Mexico (27)
New York (2965)
North Carolina (1430)
North Dakota (10)
Northern California (5686)
Ohio (324)
Oklahoma (21)
Oregon (32)
Pennsylvania (2288)
Puerto Rico (27)
Rhode Island (37)
South America (650)
South Carolina (31)
Southern California (4475)
Tennessee (143)
Texas (1636)
United States (39856)
Utah (237)
Virginia (264)
Washington D.C. (64)
Washington State (939)
West Virginia (2)
Wisconsin (111)
Wyoming (2)
510,607 Results for "global blood therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Approvals
AstraZeneca wins nod for blood pressure pill, opening new class of hypertension drugs
Baxfendy, the first aldosterone synthase inhibitor to be approved by the FDA for high blood pressure, is among the products AstraZeneca is relying on to hit its 2030 goal of $80 billion in revenue.
May 18, 2026
·
1 min read
·
Tristan Manalac
Press Releases
Roche launches the cobas MPX-E assay, a new 4-in-1 donor screening test to further safeguard the global blood supply
March 30, 2026
·
4 min read
Cardiovascular disease
Kardigan Blood Pressure Drug Proves Hypothesis Despite Split Phase 2 Readout
While tonlamarsen missed one of two co-primary endpoints, Kardigan says the drug has shown a clinically meaningful effect on blood pressure, supporting advancement into Phase 2b.
March 30, 2026
·
2 min read
·
Annalee Armstrong
Press Releases
NeuroDex and Stanford Researchers Publish First Evidence of CNS Target Engagement for GLP-1 and PPARγ Agonists Using Blood-Based Neuron-Derived Extracellular Vesicles
New study in the Journal of Clinical Endocrinology & Metabolism demonstrates that NeuroDex’s ExoSORT platform can detect central Akt–mTOR signaling changes in response to metabolic drugs — from a routine blood draw.
April 22, 2026
·
1 min read
Press Releases
Circular Genomics Finalizes Exclusive IP Licenses with Leading Global Research Institutions to Advance circRNA Blood Test for Alzheimer’s Disease
February 11, 2026
·
3 min read
Press Releases
Sarepta Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference
May 14, 2026
·
1 min read
Press Releases
Pliant Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference
May 6, 2026
·
1 min read
Press Releases
Neumora Therapeutics to Participate in 2026 RBC Capital Markets Global Healthcare Conference
May 13, 2026
·
1 min read
Press Releases
Sionna Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
May 13, 2026
·
1 min read
Press Releases
Contineum Therapeutics to Present at the 2026 RBC Capital Markets Global Healthcare Conference
May 13, 2026
·
1 min read
1 of 51,061
Next
